the response of sustained supraventricular tachycardia to intravenous and oral flecainide acetate was investigated in 5 children , aged 5.5 to 11.5 years , who had tachycardias associated with wolff-parkinson-white syndrome .
C0039240
supraventricular tachycardia
C0086303
flecainide acetate